Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.95 USD | +10.44% | +23.20% | +44.15% |
23/04 | BTIG Adjusts LifeMD's Price Target to $14 From $13, Keeps Buy Rating | MT |
12/03 | Craig-Hallum Adjusts LifeMD's Price Target to $15 From $10, Maintains Buy Rating | MT |
Evolution of the average Target Price on LifeMD, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering LifeMD, Inc.
BTIG | |
Craig-Hallum | |
Cantor Fitzgerald | |
B. Riley | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- LFMD Stock
- Consensus LifeMD, Inc.